Hilty, Matthias Peter
Favaron, Emanuele
Wendel Garcia, Pedro David
Ahiska, Yavuz
Uz, Zuhre
Akin, Sakir
Flick, Moritz
Arbous, Sesmu
Hofmaenner, Daniel A.
Saugel, Bernd
Endeman, Henrik
Schuepbach, Reto Andreas
Ince, Can
Funding for this research was provided by:
Active Medical BV
Article History
Received: 13 May 2022
Accepted: 10 October 2022
First Online: 14 October 2022
Declarations
:
: CI, MPH and YA hold share and the former are, respectively, CSO and CTO in Active Medical BV (Leiden, The Netherlands) a company who produces products (MicroTools) and services related to clinical microcirculation. The other authors declare no conflicts of interest.
: This study was approved by the ethics committee of the University of Zurich (BASEC–ID2020–00646), the Erasmus Medical Center medical ethics committee (MEC2018–1572), the ethics committee of the Hamburg Medical Association (PV5635), the Leiden University Medical Center (Coco2021–018), and the University of Bern (KEK–226/12). The study was conducted in accordance with the Declaration of Helsinki. Informed consent to participate was obtained from each volunteer, and each patient or their next of kin if they were unable to give informed consent. All collaborating centers have complied with all local legal and ethical requirements.
: CI, MPH and YA hold share and the former are, respectively, CSO and CTO in Active Medical BV (Leiden, The Netherlands) a company who produces products (MicroTools) and services related to clinical microcirculation. The other authors declare no conflicts of interest.